肺癌的TNM分类 - 一个历史的视角
1Department of Thoracic Surgery, Hospital Universitari Mútua Terrassa, University of Barcelona, Terrassa, Spain.
Journal of thoracic disease
|December 16, 2024
概括
瘤,结节和转移 (TNM) 分类对于肺癌分期至关重要,已经显著发展. 一个国际数据库现在支持其持续的治疗和研究的改进.
科学领域:
- 在瘤学瘤学.
- 癌症的分期 癌症的分期
- 临床分类 临床分类
背景情况:
- 瘤,结节和转移 (TNM) 分类是在20世纪中期由皮埃尔·F·德诺伊克斯 (Pierre F. Denoix) 开发的.
- 它是由国际癌症控制联盟 (UICC) 和美国癌症联合委员会 (AJCC) 通过的.
- 1966年,UICC发布了第一个肺癌分类,随后是第一个TNM恶性瘤分类和AJCC癌症分期手册.
研究的目的:
- 详细介绍TNM肺癌分类的历史发展和演变.
- 要突出从北美数据库向全面的国际数据库的过渡.
- 强调国际肺癌研究协会 (IASLC) 在完善分类方面的作用.
主要方法:
- 对TNM分类的发展和采用进行历史审查.
- 描述数据库从区域到国际范围的演变.
- 分析IASLC分期项目对TNM版本的贡献.
主要成果:
- 通过多个版本,TNM分类得到了改进,并得到了IASLC的重要贡献.
- 创建国际数据库解决了以前区域数据库的局限性.
- 今天使用的关键描述词起源于早期版本,证明了持续的相关性.
结论:
- TNM分类已被证明是持久的,并且仍然对肺癌治疗和研究至关重要.
- 该IASLC分期项目在TNM系统的持续准确性和全球适用性方面发挥了重要作用.
- 在肺癌管理中继续依赖解剖范围,确保了TNM分类的持久价值.
相关概念视频
01:31Pulmonary Tuberculosis III
303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
303
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K